新加坡 - 英文 - HSA (Health Sciences Authority)

ge healthcare pte. ltd. - iohexol 755 mg/ml eqv iodine - injection - 350 mg/ml - iohexol 755 mg/ml eqv iodine 350 mg/ml

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

bracco pty ltd - iopamidol, quantity: 755.3 mg/ml (equivalent: iodine, qty 370 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium calcium edetate; hydrochloric acid; trometamol - in adults, isovue is indicated for angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, peripheral venography (phlebography), coronary arteriography and ventriculography, selective visceral arteriography and aortography, intravenous excretory urography and contrast enhancement of computed tomographic head and body imaging. isovue is also indicated for myelography (lumbar, total columnar) and for contrast enhancement in computed tomography of the central nervous system. in children, isovue is indicated for intravascular use only, including intravenous excretory urography.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

bracco pty ltd - iopamidol, quantity: 755.3 mg/ml (equivalent: iodine, qty 370 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; trometamol; water for injections; sodium calcium edetate - in adults, isovue is indicated for angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, peripheral venography (phlebography), coronary arteriography and ventriculography, selective visceral arteriography and aortography, intravenous excretory urography and contrast enhancement of computed tomographic head and body imaging. isovue is also indicated for myelography (lumbar, total columnar) and for contrast enhancement in computed tomography of the central nervous system. in children, isovue is indicated for intravascular use only, including intravenous excretory urography.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

bracco pty ltd - iopamidol, quantity: 755.3 mg/ml (equivalent: iodine, qty 370 mg/ml) - injection, solution - excipient ingredients: water for injections; trometamol; hydrochloric acid; sodium calcium edetate - in adults, isovue is indicated for angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, peripheral venography (phlebography), coronary arteriography and ventriculography, selective visceral arteriography and aortography, intravenous excretory urography and contrast enhancement of computed tomographic head and body imaging. isovue is also indicated for myelography (lumbar, total columnar) and for contrast enhancement in computed tomography of the central nervous system. in children, isovue is indicated for intravascular use only, including intravenous excretory urography.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

bracco pty ltd - iopamidol, quantity: 612.4 mg/ml (equivalent: iodine, qty 300 mg/ml) - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium calcium edetate; trometamol - in adults, isovue is indicated for angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, peripheral venography (phlebography), coronary arteriography and ventriculography, selective visceral arteriography and aortography, intravenous excretory urography and contrast enhancement of computed tomographic head and body imaging. isovue is also indicated for myelography (lumbar, total columnar) and for contrast enhancement in computed tomography of the central nervous system. in children, isovue is indicated for intravascular use only, including intravenous excretory urography.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

bracco pty ltd - iopamidol, quantity: 612.4 mg/ml (equivalent: iodine, qty 300 mg/ml) - injection, solution - excipient ingredients: water for injections; trometamol; sodium calcium edetate; hydrochloric acid - in adults, isovue is indicated for angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, peripheral venography (phlebography), coronary arteriography and ventriculography, selective visceral arteriography and aortography, intravenous excretory urography and contrast enhancement of computed tomographic head and body imaging. isovue is also indicated for myelography (lumbar, total columnar) and for contrast enhancement in computed tomography of the central nervous system. in children, isovue is indicated for intravascular use only, including intravenous excretory urography.

以色列 - 英文 - Ministry of Health

eldan electronic instruments co ltd, israel - iodixanol - solution for injection - iodixanol 550 mg/ml - iodixanol - iodixanol - x- ray contrast medium for use in adults and children for cardioangiography peripheral arteriography (conventional and i.a. dsa) abdominal angiography (i.a. dsa) urography venography and ct- enhancement. pediatric use: cardioangiography urography and ct-enhancement. myelography - lumbar thoracic and cervical myelography.

以色列 - 英文 - Ministry of Health

promedico ltd - patent blue v sodium - solution for injection - patent blue v sodium 25 mg/ml - other diagnostic agents - marking lymph vessels and arterial regions.marking sentinel nodes before biopsy in patients with operable breast cancer.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

william a cook australia pty ltd - 47932 - multiple peripheral arteries stent - the device is a self-expandable stent made of nitinol. the special laser-cut pattern of the nitinol tube provides a construction with strong radial force and high flexibility. the tube is slotted and is designed to provide support while maintaining flexibility in the vessel upon deployment. post-deployment the stent is designed to impart an outward radial force upon the inner lumen of the vessel, establishing patency in the stented region, thereby maintaining constant blood flow in the vessel. the device is intended for use in the iliac, superficial femoral artery and above-the-knee popliteal artery for the treatment of arteriosclerotic stenosis, and total occlusions that have been recanalized. the device provides mechanical support to maintain constant blood flow of the vessel.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

bard australia pty ltd - 47932 - multiple peripheral arteries stent - it is a self expanding, flexible, nitinol (nickel-titanium alloy) stent that expands to its preset diameter upon exposure to body temperature. it has a segmental repeating pattern and an open cell geometry with flared ends to help prevent dislocation or migration. partial cuts around the circumference of the stent cylinder provide enhanced flexibility and allow segment-by-segment expansion. the device is mr conditional under 3t. the e-luminexx vascular stent is indicated for use in iliac and femoral arteries: - residual stenoses with impaired perfusion (pressure gradient) following balloon dilatation, especially in stages iii and iv according to fontaine. - dissection. - detached arteriosclerotic plaque material and luminal obstruction following balloon dilatation. - occlusion after thrombolysis or after aspiration and before dilatation. - restenosis or reocclusion.